SCICLONE PHARMACEUTICALS (HLDGS) LT revenue breakdown overview

SCICLONE PHARMACEUTICALS (HLDGS) LT revenue for the last year amounted to 3.47 B HKD, the most of which — 3.49 B HKD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 3.20 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SCICLONE PHARMACEUTICALS (HLDGS) LT 3.37 B HKD, and the year before that — 3.10 B HKD.